全文获取类型
收费全文 | 981篇 |
免费 | 55篇 |
国内免费 | 4篇 |
专业分类
耳鼻咽喉 | 10篇 |
儿科学 | 39篇 |
妇产科学 | 15篇 |
基础医学 | 93篇 |
口腔科学 | 2篇 |
临床医学 | 77篇 |
内科学 | 126篇 |
皮肤病学 | 12篇 |
神经病学 | 62篇 |
特种医学 | 50篇 |
外科学 | 157篇 |
综合类 | 155篇 |
预防医学 | 57篇 |
眼科学 | 16篇 |
药学 | 73篇 |
中国医学 | 1篇 |
肿瘤学 | 95篇 |
出版年
2023年 | 5篇 |
2022年 | 11篇 |
2021年 | 28篇 |
2020年 | 15篇 |
2019年 | 22篇 |
2018年 | 22篇 |
2017年 | 16篇 |
2016年 | 23篇 |
2015年 | 20篇 |
2014年 | 24篇 |
2013年 | 28篇 |
2012年 | 40篇 |
2011年 | 35篇 |
2010年 | 37篇 |
2009年 | 44篇 |
2008年 | 52篇 |
2007年 | 44篇 |
2006年 | 43篇 |
2005年 | 39篇 |
2004年 | 39篇 |
2003年 | 26篇 |
2002年 | 35篇 |
2001年 | 33篇 |
2000年 | 21篇 |
1999年 | 19篇 |
1998年 | 30篇 |
1997年 | 34篇 |
1996年 | 28篇 |
1995年 | 5篇 |
1994年 | 14篇 |
1993年 | 12篇 |
1992年 | 11篇 |
1991年 | 19篇 |
1990年 | 12篇 |
1989年 | 17篇 |
1988年 | 15篇 |
1987年 | 12篇 |
1986年 | 10篇 |
1985年 | 13篇 |
1984年 | 11篇 |
1983年 | 10篇 |
1982年 | 4篇 |
1981年 | 9篇 |
1980年 | 7篇 |
1979年 | 4篇 |
1978年 | 5篇 |
1977年 | 6篇 |
1976年 | 7篇 |
1974年 | 4篇 |
1967年 | 4篇 |
排序方式: 共有1040条查询结果,搜索用时 0 毫秒
11.
12.
Intra-arterial tissue adhesive for medical splenectomy in humans 总被引:2,自引:0,他引:2
13.
Fluorescent in vivo tracking of hematopoietic cells. Part I. Technical considerations 总被引:3,自引:1,他引:3
We report a new technology for in vivo tracking of hematopoietic cells, using fluorescent lipophilic probes. Because the probe is irreversibly bound in the lipids of the cell membrane; substantial numbers of dye molecules can be incorporated per cell and thus substantial signal to noise can be achieved. Although this technology can be used for all hematopoietic cells, these first findings are reported on red blood cells (RBCs) owing to the importance of the membrane to RBC function and integrity. We demonstrated that labeling 10% of the RBCs of a rabbit and reinjecting them into the animal makes possible the tracking of these cells at various times after injection. Furthermore, the labeling appears not to affect in vivo cell lifetime or cellular volume changes in response to hypotonic shock. The single cell fluorescence intensity of the labeled RBCs remains relatively constant for 60 days, and an immune response appears not to be generated against labeled cells. That labeled RBCs have lifetime kinetics in vivo, as shown in other studies, indicates that the membranes are functioning normally and are unaltered by the labeling technology. The technology we present is also applicable to white blood cells, bone marrow, and platelets. 相似文献
14.
15.
Hemalatha Parangusan Jolly Bhadra Zubair Ahmad Shoaib Mallick Farid Touati Noora Al-Thani 《RSC advances》2020,10(45):26604
Polyaniline (PANI)/Cu–ZnS composites with porous microspheres are prepared by a hydrothermal and in situ polymerization method. The structural, optical, and morphological properties are characterized by X-ray powder diffraction, FTIR, UV-vis, scanning electron microscope, transmission electron microscope. The XRD results confirmed that the PANI/Cu–ZnS composite is formed. The morphological analyses exhibited that the PANI/Cu–ZnS composite comprises the porous microspherical structures. The emission peaks obtained in photoluminescence spectra confirm the presence of surface defects in the prepared composite. The UV-DRS study shows that the bandgap of the samples is found to decrease for the PANI/Cu–ZnS composite compared to the pure Cu–ZnS sample. The calculated band gap (Eg) value of PANI/Cu–ZnS composite is 2.47 eV. Furthermore, the fabricated gas sensor based on PANI/Cu–ZnS can perform at room temperature and exhibits good gas sensing performance toward CO2 gas. In particular, PANI/Cu–ZnS sensor shows good response (31 s) and recovery time (23 s) upon exposure to CO2 gas. The p/n heterojunction, surface defects, and porous nature of the PANI/Cu–ZnS composite microsphere enhanced sensor performance.Polyaniline (PANI)/Cu–ZnS composites with porous microspheres are prepared by a hydrothermal and in situ polymerization method. 相似文献
16.
17.
Internal medicine resident knowledge of transfusion medicine: results from the BEST‐TEST international education needs assessment 下载免费PDF全文
18.
19.
20.
Ambulatory blood pressure (BP) monitoring is superior to clinic BP monitoring in predicting long-term consequences of hypertension. This has raised interest in diurnal variation in BP and elevation in nighttime BP as a prognostic and therapeutic target. Several studies have identified prevalence of nocturnal hypertension in patients with accelerated progression of chronic kidney disease and target organ damage. Some studies suggest that nocturnal BP can be lowered by changing administration of antihypertensive medication to bed time; whether that results in retarding kidney disease progression is not very clear. Further research is needed to determine if certain classes of medications or interventions are superior in controlling nocturnal hypertension, and protocols need to be developed to screen patients for monitoring nocturnal BP. Further studies are needed to evaluate long-term renal outcomes of evening dosing in patients with nocturnal hypertension and chronic kidney disease. 相似文献